Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Drug Allergy
•
Hospital Medicine
How do you manage an iodinated contrast allergy leading to grade 5 anaphylaxis in a patient who will foreseeably need another iodinated contrast agent in the future?
Related Questions
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
Excluding CLL, in which patients would you screen for hypogammaglobulinemia?
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
Do you recommend desensitization to biologics since this has to occur repeatedly?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
Do you believe that pretreatment with montelukast or other LTRAs can reduce the risk of urticaria or angioedema with NSAIDS?
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?
Are there specific conventional DMARDs and/or biologics that are contraindicated in patients with alpha-gal allergy?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
Would you consider rechallenging immunotherapy if the first dose was accompanied with an acute infusion reaction with low back pain, shortness of breath and chest pain which resolved with monitoring, and subsequent cardiac workup being negative?
